Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers

被引:223
作者
El-Sayed, M
Ginski, M
Rhodes, C
Ghandehari, H
机构
[1] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA
[2] Guilford Pharmaceut Inc, Dept Pharmaceut, Baltimore, MD 21224 USA
关键词
poly (amidoamine) dendrimers; PAMAM; Caco-2; cells; transepithelial transport; drug delivery;
D O I
10.1016/S0168-3659(02)00087-1
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The objective of this study was to investigate the influence of physiochemical parameters (such as size, molecular weight, molecular geometry, and number of surface amine groups) of poly (amidoamine) (PAMAM) dendrimers, on their permeability across Caco-2 cell monolayers: The permeability of a series of PAMAM dendrimers, generations 0-4 (G0-G4), was investigated across Caco-2 cell monolayers in both the apical to basolateral (AB) and basolateral to apical (BA) directions. The influence of PAMAM dendrimers on the integrity, paracellular permeability, and viability of Caco-2 cell monolayers was also monitored by measuring the transepithelial electrical resistance (TEER), mannitol permeability, and leakage of lactate dehydrogenase (LDH) enzyme, respectively. G0, G1 and G2 demonstrated similar AB permeabilities, which were moderate several fold higher than the AB permeability of higher generations. The AB and BA permeability of G0-G4 typically increased with the increase in donor concentration and incubation time. Permeability values are not reported at generations, concentrations or incubation times that the dendrimers were toxic to Caco-2 cells. TEER values decreased and mannitol permeability increased as a function of donor concentration, incubation time, and generation number. LDH results for G3 and G4 indicate that Caco-2 cell viability was reduced with increasing donor concentration, incubation time, and generation number. The appreciable permeability of G0-G2, coupled with their nontoxic effects on Caco-2 cells, suggest their potential as water-soluble polymeric drug carriers for controlled oral drug delivery. (C) 2002 Elsevier Science B V All rights reserved.
引用
收藏
页码:355 / 365
页数:11
相关论文
共 23 条
[1]  
[Anonymous], 1993, ALDRICHIM ACTA
[2]   SELECTIVE PARACELLULAR PERMEABILITY IN 2 MODELS OF INTESTINAL-ABSORPTION - CULTURED MONOLAYERS OF HUMAN INTESTINAL EPITHELIAL-CELLS AND RAT INTESTINAL SEGMENTS [J].
ARTURSSON, P ;
UNGELL, AL ;
LOFROTH, JE .
PHARMACEUTICAL RESEARCH, 1993, 10 (08) :1123-1129
[3]   The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption .3. Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro [J].
Borchard, G ;
Luessen, HL ;
deBoer, AG ;
Verhoef, JC ;
Lehr, CM ;
Junginger, HE .
JOURNAL OF CONTROLLED RELEASE, 1996, 39 (2-3) :131-138
[4]   In vitro myotoxicity of selected cationic macromolecules used in non-viral gene delivery [J].
Brazeau, GA ;
Attia, S ;
Poxon, S ;
Hughes, JA .
PHARMACEUTICAL RESEARCH, 1998, 15 (05) :680-684
[5]   Comparison of HT29-18-C-1 and Caco-2 cell lines as models for studying intestinal paracellular drug absorption [J].
Collett, A ;
Sims, E ;
Walker, D ;
He, YL ;
Ayrton, J ;
Rowland, M ;
Warhurst, G .
PHARMACEUTICAL RESEARCH, 1996, 13 (02) :216-221
[6]   Extravasation of poly(amidoamine) (PAMAM) dendrimers across microvascular network endothelium [J].
El-Sayed, M ;
Kiani, MF ;
Naimark, MD ;
Hikal, AH ;
Ghandehari, H .
PHARMACEUTICAL RESEARCH, 2001, 18 (01) :23-28
[7]  
Fleisher D., 1995, PEPTIDE BASED DRUG D, P501
[8]  
Ghandehari H, 1997, J PHARMACOL EXP THER, V280, P747
[9]   Paracellular diffusion in Caco-2 cell monolayers: Effect of perturbation on the transport of hydrophilic compounds that vary in charge and size [J].
Knipp, GT ;
Ho, NFH ;
Barsuhn, CL ;
Borchardt, RT .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (10) :1105-1110
[10]   Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments:: In vitro evaluation in intestinal epithelial cells (Caco-2) [J].
Kotzé, AF ;
Thanou, MM ;
Lueben, HL ;
de Boer, AG ;
Verhoef, JC ;
Junginger, HE .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (02) :253-257